Nov 2026· Frontiers in Pharmacology· Vol 17· 0 citations· 58 references
TL;DR
Combining LL-37 with TP5 generated a peptide with favorable antimicrobial, endotoxin-neutralizing, and anti-inflammatory properties together with an improved safety profile compared with native LL-37, indicating that hybridization of LL-37 with TP5 generated a peptide with favorable antimicrobial, endotoxin-neutralizing, and anti-inflammatory properties.
Abstract
The increasing prevalence of antimicrobial resistance and endotoxin-mediated inflammation highlights the need for alternative therapeutic strategies that combine antibacterial and immunomodulatory functions. Although cathelicidin LL-37 exhibits potent antimicrobial and lipopolysaccharide (LPS)-neutralizing activity, its clinical application is limited by cytotoxicity and high production costs. A hybrid peptide, LL37-TP5, was designed by fusing the active LPS-binding region of LL-37 (residues 13–36) with the immunomodulatory penta peptide thymopentin (TP5) to enhance endotoxin-neutralizing activity while reducing host cytotoxicity. Bioinformatics analyses predicted that LL37-TP5 adopt amphipathic α-helical structure with optimized hydrophobicity and a strong net positive (+9) charge. The hybrid peptide was successfully expressed recombinantly in
Pichia pastoris (P. pastoris)
and purified by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), yielding approximately 20.5 mg/L with 95.2% purity, consistent with
in silico
predictions. Considering the increasing prevalence of antimicrobial resistance in poultry production, the antibacterial activity of LL37-TP5 was evaluated against major poultry-associated bacterial pathogens. LL37-TP5 exhibited broad-spectrum antibacterial activity against Gram-negative and Gram-positive bacteria, with low minimum inhibitory and bactericidal concentrations. Furthermore, the hybrid peptide showed enhanced LPS-neutralizing activity and significantly suppressed nitric oxide and pro-inflammatory cytokine (IL-6, TNF-α, and IL-1β) production in LPS-stimulated RAW264.7 macrophages. Importantly, LL37-TP5 demonstrated markedly reduced cytotoxicity and negligible hemolytic activity compared with parental LL-37. Collectively, our findings indicate that hybridization of LL-37 with TP5 generated a peptide with favorable antimicrobial, endotoxin-neutralizing, and anti-inflammatory properties together with an improved safety profile compared with native LL-37.
While the peptide shows promising in vitro dual antibacterial and toxin-neutralizing capacity, its high sensitivity to proteinase K limits oral application.
En Liu, Wei-Ping Huo, Fu-Li Xu et al.· Applied Biochemistry and Bio...· 0 citations
Given the surge in antibiotic resistance, antimicrobial peptides have emerged as promising alternatives to conventional antibiotics; however, their therapeutic potential remains hindered by proteolytic instability and insufficient potency. Herein, we integrated an anti-proteolytic Arg-Pro scaffold with N-terminal fatty...
Jia-Jun Wang, Hao-Ran Xu, Yu Sun et al.· Cell Chemical Biology· 0 citations
The consensus-sequence approach toward novel Brevinin-2 AMP discovery via alignment combined with in vitro antimicrobial analysis shows promise to test and initially validate other peptides, and establishes a streamlined pipeline for Brevinin-2 peptide development.
Colin M. McDowell, Jessica D. Carder, J. Brozik et al.· Applied and Environmental Mi...· 0 citations
The human cathelicidin LL-37 is one of the most promising candidates for replacing standard antibiotics due to its broad-spectrum activity and low propensity for resistance development. However, the widespread clinical adoption of antimicrobial peptides (AMPs) is currently limited by the high cost and several con...
Laura Colomina-Alfaro, Mih-Yun Lee, Si-Xuan Zhang et al.· Applied Microbiology and Bio...· 0 citations
The rise of antimicrobial resistance among ESKAPE pathogens demands novel therapeutic strategies. Here, we evaluate a panel of five synthetic peptides through integrated in vitro and in silico analyses, highlighting PEP-4 as a promising antibacterial lead peptide. Our findings demonstrate the key role of C-terminal hyd...
I. L. Pereira, Isadora Leitzke Guidotti, Danillo de Oliveira Della Senta et al.· ACS Omega· 0 citations
Respiratory viral–bacterial co-infections remain difficult to treat because current therapies typically target pathogens individually. In this study, we designed and computationally evaluated a dual-function chimeric antimicrobial peptide that integrates the conserved antiviral and antibacterial domains of LL-37 and hu...
G. Ghaznavi, Navid Nezafat, C. Irajie et al.· Future Journal of Pharmaceut...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.